Modulation of MUC1 mucin as an escape mechanism of breast cancer cells from autologous cytotoxic T-lymphocytes

British Journal of Cancer
K KontaniR Kannagi

Abstract

MUC1 mucin is known to serve as a target molecule in the killing of breast cancer cells by cytotoxic T-lymphocytes (CTLs). We searched for a possible mechanism allowing tumour cells to escape from autologous CTLs. When the killing of breast cancer cells by autologous lymphocytes was examined in 26 patients with breast cancer, significant tumour cell lysis was observed in 8 patients, whereas virtually no autologous tumour cell lysis was detected in as many as 18 patients. In the patients who showed negligible tumour cell lysis, the autologous tumour cells expressed MUC1-related antigenic epitopes much more weakly than the tumour cells in the patients who exhibited strong cytotoxicity (significant statistically at P< 0.0005-0.0045), suggesting that the unresponsiveness of cancer cells to CTLs observed in these patients was mainly due to loss of MUC1 expression or modulation of its antigenicity. A breast cancer cell line, NZK-1, established from one of the cytotoxicity-negative patients, did not express MUC1 and was resistant to killing by CTLs, while control breast cancer cell lines expressing MUC-1 were readily killed by CTLs. Transfection of NZK-1 cells with MUC1 cDNA induced significant lysis by autologous T-lymphocytes. These...Continue Reading

Citations

Jan 15, 2009·Cancer Research·Zdravka MedarovaAnna Moore
Jun 22, 2011·Expert Opinion on Biological Therapy·Luis Corrales-RodriguezDenis Soulières
Aug 19, 2015·Frontiers in Oncology·Malgorzata WachowskaJakub Golab
Oct 13, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Deirdre O'MahonyMartin E Gutierrez
Jun 26, 2007·Current Oncology Reports·Carol Albright, Jennifer Garst
Jul 1, 2005·The Journal of Biological Chemistry·Fiana LevitinDaniel H Wreschner
Jan 28, 2006·Journal of Cellular Biochemistry·Devin B LoweRonald C Kennedy
Nov 30, 2019·Journal for Immunotherapy of Cancer·Andrew B NixonCatherine Fleener
Feb 2, 2018·Molecular and Clinical Oncology·Kensuke OkanoHiroshi Kijima
Mar 27, 2003·BJU International·D P ScholfieldM C Bishop
Jan 10, 2013·Scandinavian Journal of Immunology·A Anandkumar, H Devaraj
Jul 23, 2004·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·David AviganDonald Kufe
Aug 8, 2008·Seminars in Immunology·Andrea SchietingerHans Schreiber

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.